Antimicrobial resistance in human oral and intestinal anaerobic microfloras
Open Access
- 1 August 1993
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 37 (8) , 1665-1669
- https://doi.org/10.1128/aac.37.8.1665
Abstract
In the present study we determined the resistance patterns of anaerobic bacteria from human saliva and stool specimens and investigated whether there were significant differences in resistance between outpatients and hospitalized patients, regardless of whether they had received antimicrobial agents. No bacterial strains resistant to ampicillin, piperacillin, cefoxitin, cefuroxime, imipenem, clindamycin, doxycycline, chloramphenicol, or metronidazole were isolated from the saliva samples. However, resistance to ampicillin, cefoxitin, and cefuroxime was found in strains from 70% of the fecal samples (mainly Bacteroides thetaiotaomicron, Clostridium innocuum, and Bacteroides ovatus). Resistance to both ampicillin and cefuroxime was frequently found in 19% of the isolated strains (mainly B. thetaiotaomicron, B. ovatus, and Bacteroides vulgatus). No strains that were resistant to imipenem, chloramphenicol, or metronidazole were found. Hospitalization and/or intake of antimicrobial agents was associated with an increase in the relative number of resistant anaerobic intestinal bacteria. The percentage of resistant anaerobic strains encountered, compared with the total number of anaerobic bacteria in the normal fecal microflora, was between 5.2 and 14.8%, with the lower value associated with the outpatient group. Two-thirds of the resistant strains from this group had a relative frequency of less than 1% of the total anaerobic flora, while one-third of the strains were present at a level of greater than 1%; for the hospitalized patients, two-thirds of the strains were present at a level of greater than 1%, and one-third of the strains were present at a level of less than 1% (P < 0.001). Patients who had received antimicrobial agents for 6 days or more (n=20) had an average of 1.6 resistant anaerobic strains each, while patients treated for 3 to 5 days (n = 30) had a mean number of 0.87 resistant strains each ( P < 0.05).Keywords
This publication has 14 references indexed in Scilit:
- Clinical relevance of antimicrobial susceptibility testingEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Survey of Bacteroides fragilis group susceptibility patterns in CanadaAntimicrobial Agents and Chemotherapy, 1992
- Purification and characterization of an imipenem hydrolysing metallo-β-lactamase from Bacteroides fragilisJournal of Antimicrobial Chemotherapy, 1992
- Anaerobic Bacterial Bacteremia: 12-Year Experience in Two Military HospitalsThe Journal of Infectious Diseases, 1989
- A 7-Year Survey of Drug Resistance in Aerobic and Anaerobic Fecal Bacteria of Surgical Inpatients: Clinical Relevance and Relation to Local Antibiotic ConsumptionScandinavian Journal of Infectious Diseases, 1989
- High frequency of antimicrobial resistance in human fecal floraAntimicrobial Agents and Chemotherapy, 1988
- Cefoxitin resistance in Bacteroides species: evidence indicating two mechanisms causing decreased susceptibilityJournal of Antimicrobial Chemotherapy, 1987
- Beta-lactamase-mediated imipenem resistance in Bacteroides fragilisAntimicrobial Agents and Chemotherapy, 1986
- Effect of Phenoxymethylpenicillin and Clindamycin on the Oral, Throat and Faecal Microflora of ManScandinavian Journal of Infectious Diseases, 1979
- Effect of stay in hospital and oral chemotherapy on the antibiotic sensitivity of bowel coliformsEpidemiology and Infection, 1973